We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Cervicovaginal DNA Virome Alterations Associated with Genital Inflammation

By LabMedica International staff writers
Posted on 08 Apr 2022

Cervical cancer is one of the most common cancers among women. More...

In 2021, more than 600,000 cases and 340,000 deaths were reported worldwide. In addition to infection with the human papillomavirus (HPV), known risk factors for cervical cancer include immunodeficiency, smoking and oral contraceptive use.

The healthy vaginal bacterial microbiome is dominated by Lactobacillus species. Bacterial vaginosis, characterized by low Lactobacillus abundance and overrepresentation of anaerobes, including Gardnerella, Prevotella, Atopobium, Sneathia, Megasphaera, and others, has been associated with HPV infection and cervical intraepithelial neoplasia.
Medical Scientists at the Arizona State University (Temple, AZ, USA) included in a study a subset of 28 premenopausal, non-pregnant women. Vaginal swabs and cervicovaginal lavage (CVL) samples were collected by a physician. The first vaginal swab was collected using an Eswab collection system with Amies transport medium (Copan Diagnostics, Murrieta, CA, USA) and used for HPV genotyping and 16S rRNA sequencing analyses. CVL samples were collected using 10 mL of sterile 0.9% saline and used for multiplex cytokine and virome analyses.

Women were classified as HPV negative or positive. HPV status was determined with a linear array HPV genotyping test (Roche Diagnostics, Indianapolis, IN, USA), which detects 37 anogenital HPV genotypes. Vaginal bacterial microbiome analysis was performed previously by 16S rRNA gene sequencing using DNA extracted from vaginal swabs and sequenced for 250 cycles on the MiSeq platform (Illumina, San Diego, CA, USA). A multiplex cytokine assay was performed using Milliplex MAP human cytokine/chemokine and Th17 magnetic bead panels (Millipore, Burlington, MA, USA).

The investigators reported that specific virome alterations were associated with features of the local microenvironment related to HPV persistence and progression to cervical cancer. Cervicovaginal viromes clustered distinctly by genital inflammation state. Genital inflammation was associated with decreased virome richness and alpha diversity and an increased abundance of Anelloviridae species from the genus Alphatorquevirus. Lactobacillus bacteriophages were closely associated with increased Lactobacillus abundance, consistent with phage-host relationships. Interestingly, bacteria-bacteriophage transkingdom interactions were linked to genital inflammation and showed specific interactions with bacterial vaginosis-associated bacteria, including Gardnerella, Prevotella, and Sneathia.

The authors concluded that they had identified associations between cervicovaginal DNA virome composition and bacterial microbiome and genital inflammation. Both vaginal Lactobacillus relative abundance and genital inflammation were associated with changes in the cervicovaginal virome. Anelloviridae species, including Alphatorquevirus species, were also associated with genital inflammation. Additionally, they observed distinct bacteria-bacteriophage transkingdom interactions between established disease-associated bacteria and bacteriophages. The study was published on March 28, 2022 in the journal mSystems.


Related Links:
Arizona State University
Copan Diagnostics
Roche Diagnostics
Millipore
Illumina



 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Urine Analyzer
respons® UDS100
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Prehospital Blood Test Could Reduce Emergency Transfers for Chest Pain

Chest pain leads to ambulance transport to an emergency department for about 95% of patients, although only a minority have a serious cardiac condition. Troponin testing helps assess heart muscle damage,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: RealTime Labs’ Mycotoxin Extensive Panel measures 31 mold-related toxins across seven toxin classes from a single urine sample (Photo courtesy of RealTime Labs)

New Urine Test Expands Mycotoxin Analysis to 31 Markers for Broader Exposure Assessment

Clinical evaluation of mold exposure increasingly relies on urinary mycotoxin testing, but limited marker coverage and metabolite masking can make results more difficult to interpret. Broader analysis... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.